Events2Join

Repligen Corporation Common Stock


Repligen Corporation (RGEN) - Yahoo Finance

Yahoo Finance · Repligen Corporation (RGEN).

Repligen Corp. Stock Quote (U.S.: Nasdaq) - RGEN - MarketWatch

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing ...

Repligen Corporation Common Stock (RGEN) - Nasdaq

Discover real-time Repligen Corporation Common Stock (RGEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment ...

Stock Information - Stock Quote - Press Releases | Repligen - Q4

Repligen Corporation (NASDAQ - RGEN) · Stock Chart · Historic Price Look Up.

RGEN: Repligen Corp - Stock Price, Quote and News - CNBC

Repligen Corp RGEN:NASDAQ · Open148.58 · Day High149.88 · Day Low145.43 · Prev Close150.47 · 52 Week High211.13 · 52 Week High Date02/16/24 · 52 Week Low113.50 · 52 ...

RGEN | Repligen Corp. Stock Overview (U.S.: Nasdaq) - Barron's

Repligen Corp. ; Market Value, $8.32B ; Shares Outstanding, 56.01M ; EPS (TTM), -$0.37 ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A.

Repligen Corporation (RGEN) Stock Price, Quote, News & Analysis

Repligen Corporation's stock symbol is RGEN and currently trades under NASDAQ. It's current price per share is approximately $149.91. How much money does ...

Repligen Stock Price Today | NASDAQ: RGEN Live - Investing.com

The stock ticker symbol for Repligen Corporation is RGEN. Is RGEN the Same as $RGEN? $RGEN is a common way to refer to the Repligen Corporation ticker ...

RGEN Stock Price and Chart — NASDAQ:RGEN - TradingView

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing ...

Repligen (RGEN) Stock Price, News & Info | The Motley Fool

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing ...

RGEN Stock Quote - Repligen Stock Price & News - AInvest

About. Repligen Corporation is a leading supplier of critical products used to manufacture biologic drugs. The company manufactures Protein A for major life ...

Repligen Corp (RGEN) Stock Price & News - Google Finance

Get the latest Repligen Corp (RGEN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading ...

Repligen Stock Price Forecast. Should You Buy RGEN?

A very red day for Repligen Corporation stock price after a -5.34% fall in the Thursday trading session. (Updated on Nov 14, 2024) · -5.78% during the next 3 ...

Repligen Corporation (RGEN) Stock Forecast & Price Target

From what 6 stock analysts predict, the share price for Repligen Corp (RGEN) might increase by 38.38% in the next year. This is based on a 12-month average ...

RGEN - Repligen Corp Latest Stock News & Market Updates

Welcome to our dedicated page for Repligen news (Ticker: RGEN), a resource for investors and traders seeking the latest updates and insights on Repligen ...

Investors - Repligen

FINANCIAL INFORMATION · INTERACTIVE ANALYST CENTER · SEC FILINGS · ANNUAL REPORTS · STOCK INFORMATION · STOCK QUOTE ... © 2024 Repligen Corporation. All rights ...

RGEN - Repligen Corp Stock Price - Barchart.com

Market Capitalization, $K · 7,814,655 ; Shares Outstanding, K · 56,007 ; Annual Sales, $ 638,760 K ; Annual Income, $ 41,580 K ; EBIT $ 7 M ...

Repligen Corporation (RGEN) Stock Price, Quote & News

According to 10 analysts, the average rating for RGEN stock is "Buy." The 12-month stock price forecast is $190.25, which is an increase of 24.83% from the ...

Repligen Corporation Stock (RGEN) - Quote Nasdaq- MarketScreener

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems.

RGEN: Repligen Corp Stock Price Quote - NASDAQ GS - Bloomberg

Stock analysis for Repligen Corp (RGEN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.